Natural Management

What Actually Goes Wrong in Dry Eye

The tear film is a three-layer structure that keeps the ocular surface healthy, optically smooth, and protected from the environment. The outermost lipid layer — secreted by the meibomian glands located along the eyelid margins — prevents the aqueous layer beneath it from evaporating too quickly. The middle aqueous layer, produced by the lacrimal glands, delivers nutrients, oxygen, and immune factors to the cornea. The innermost mucin layer, secreted by goblet cells in the conjunctiva, helps the tear film adhere to the corneal surface.

Dry eye comes in two principal forms that often overlap:

Aqueous-deficient dry eye (ADDE) — the lacrimal glands produce too little watery component. This is more common in Sjögren's syndrome, post-menopausal women, and people on antihistamines, antidepressants, or beta-blockers (which all reduce aqueous secretion).

Evaporative dry eye (EDE) — the aqueous layer evaporates too quickly because the meibomian glands are blocked or inflamed, producing an insufficient or poor-quality lipid layer. This is by far the more common form, accounting for roughly 85% of dry eye cases. Meibomian gland dysfunction (MGD) involves thickening of the meibum secretions, blockage of the gland openings, and in some cases, gland atrophy from chronic obstruction. Screen use worsens EDE because the blink rate drops by 60–70% when staring at a screen, reducing the mechanical spreading of meibum across the tear film.

Understanding which type predominates matters because the interventions differ somewhat — MGD responds particularly well to heat therapy and lipid-replenishing drops, while ADDE responds more to aqueous-replacement drops and anti-inflammatory strategies.

Warm Compress Therapy — the Foundation for MGD

For the most common form of dry eye (meibomian gland dysfunction), warming the eyelids softens the thickened meibum so it can flow freely from the glands when the eyes are gently massaged. Studies show that sustained eyelid warming to above 40°C (104°F) for 10–15 minutes is necessary to melt the lipid secretions — a warm face cloth cools too rapidly to be consistently effective. Purpose-made eyelid warming masks that maintain temperature for 10 minutes are the best-studied approach.

A randomised, controlled trial comparing different warming devices in 58 people with MGD found that sustained-heat devices produced significantly greater symptom improvement at 3 months than warm towels (78% of participants reporting symptomatic improvement vs. 46%, p=0.023). [5] The optimal protocol for most people:

• Apply a warm compress over closed eyes for 10–12 minutes, once daily
• Immediately follow with gentle massage of the upper and lower eyelid margins (pushing meibum toward the lid edge) for 1–2 minutes
• Clean the eyelid margins with a warm, clean cloth or dedicated lid wipes to clear any debris from the gland openings

Results typically take 2–4 weeks of consistent daily practice before symptomatic improvement is noticeable. For established MGD, this is not a temporary measure — it is best maintained as a permanent daily habit, much like brushing teeth.

Castor oil applied topically provides an additional benefit: its primary component, ricinoleic acid, supplements the meibomian lipid layer and resists evaporation better than aqueous tears. Castor oil also has anti-inflammatory and antimicrobial properties that may reduce the bacterial biofilm (including Staphylococcus epidermidis and Demodex mites) that contributes to lid margin inflammation. A handful of randomised trials show that low-concentration castor oil eye drops increase tear film lipid layer thickness, reduce evaporation, and improve ocular surface staining scores compared to conventional artificial tear drops. [5] Purpose-formulated ophthalmic castor oil drops are available; applying a small amount to closed eyelid margins at night is an alternative approach used in some studies.

Omega-3 Fatty Acids

The omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) reduce tear film inflammation through several mechanisms: they shift prostaglandin synthesis toward less inflammatory E3-series prostaglandins, suppress NF-κB-mediated cytokine production in the conjunctival epithelium, improve the lipid composition of meibomian secretions, and increase goblet cell density (restoring the mucin layer). DHA is also a structural component of photoreceptor membranes and has a direct presence in lacrimal gland tissue.

The clinical picture for omega-3 supplementation in dry eye is broadly positive, though with some nuance. A 2023 updated meta-analysis pooling 8 randomised controlled trials with 1,107 total participants found that omega-3 supplementation produced a statistically significant improvement in the OSDI (Ocular Surface Disease Index) symptom score — the most validated patient-reported outcome measure in dry eye research — compared to placebo. [1] Tear break-up time (TBUT), which measures how quickly the tear film destabilises after a complete blink, also improved in most included trials.

The prominent 2018 DREAM trial (a large US government-funded RCT of 535 patients) showed no benefit for omega-3 versus refined olive oil placebo — but critics noted that the olive oil placebo was not biologically inert (olive oil has anti-inflammatory oleocanthal content) and that the dose (3g/day combined EPA+DHA) may have been insufficient for the severity of disease enrolled. Most other RCTs have used higher doses (3–6g/day total omega-3) or recruited populations at earlier stages of disease.

Practical guidance: aim for 2–3 portions of oily fish per week (sardines, mackerel, salmon, herring) plus 2–3g of combined EPA+DHA from a triglyceride-form fish oil supplement daily. Choose a re-esterified triglyceride formulation for better absorption than ethyl ester forms. See our Omega-3 page for more on sources and bioavailability.

Vitamin D

Vitamin D has broad immunomodulatory and anti-inflammatory effects throughout the body, and the conjunctiva and lacrimal gland both express vitamin D receptors. Several mechanisms connect vitamin D deficiency to dry eye: insufficient vitamin D impairs the function of regulatory T cells (Tregs) that normally suppress conjunctival inflammation, reduces the secretion of anti-inflammatory cytokines like IL-10, and may directly impair lacrimal gland function.

A 2020 meta-analysis of 10 studies involving 18,919 participants found that people with dry eye syndrome had mean serum vitamin D levels approximately 4 ng/ml lower than controls — and that lower serum vitamin D was significantly associated with worse subjective symptom scores (OSDI) and lower Schirmer's test values (a measure of aqueous tear production). [3]

Crucially, supplementing in deficient people measurably improves clinical parameters. An RCT randomised 100 people with dry eye disease who were vitamin D-deficient (<20 ng/ml) to 8 weeks of oral vitamin D supplementation or conventional treatment alone. The supplemented group showed significantly greater improvements: Schirmer's test improved by 2.38 vs 0.7mm (p<0.001), tear break-up time improved by 3.95 vs 0.92 seconds (p<0.001), and tear osmolarity (a direct measure of tear film quality) improved by 16.9 vs 3.34 mOsm/L (p<0.001). [2]

Getting vitamin D levels tested (via 25-OH vitamin D blood test) and optimising to 40–60 ng/ml is a reasonable step for anyone with chronic dry eye, particularly those with limited sun exposure. See our Vitamin D page for dosing guidance.

Probiotics and the Gut-Eye Axis

An emerging field of research explores how the gut microbiome influences ocular surface health — the "gut-eye axis." The proposed mechanisms include microbial modulation of systemic cytokine levels (particularly IL-6, IL-17, and TNF-α), regulation of IgA secretion that affects mucosal surfaces throughout the body (including the conjunctiva), and effects on nerve growth factor pathways relevant to lacrimal gland function.

A randomised, double-masked 4-month clinical trial in 41 people with dry eye compared an oral probiotic-prebiotic combination (containing Lactobacillus and Bifidobacterium species) versus placebo. The probiotic group showed improvements in tear secretion (Schirmer's test), ocular surface staining scores, and dry eye symptom questionnaire scores that were not seen in the placebo group. [4] This is early-stage evidence from a small trial, but it adds to a broader body of literature showing that the gut microbiome influences systemic and local inflammatory tone in ways that affect mucosal surfaces including the conjunctiva.

Fermented foods (kefir, yoghurt, kimchi, sauerkraut), a diverse fibre-rich diet, and targeted probiotic supplementation are reasonable additions to a broader dry eye management strategy. See our Probiotics page for guidance on strains with the best clinical evidence.

Reducing Screen Exposure and Blink Rate

Incomplete blinking and reduced blink frequency during screen use are among the most significant modifiable drivers of evaporative dry eye in the modern environment. During focused screen work, the blink rate drops from a natural 15–20 blinks per minute to 5–7 blinks per minute — and many of these reduced blinks are incomplete (the upper lid doesn't fully contact the lower lid), meaning the meibomian glands aren't being expressed and the tear film isn't being fully renewed.

Practical strategies:

• Follow the 20-20-20 rule: every 20 minutes, look at something 20 feet away for at least 20 seconds (this allows complete blink cycles and reduces accommodative fatigue)
• Consciously blink fully every few minutes when doing sustained near work
• Position screens slightly below eye level — looking slightly downward reduces the exposed ocular surface area compared to looking straight ahead or upward
• Increase ambient humidity in dry indoor environments (target 40–60% relative humidity); use a humidifier in air-conditioned or centrally heated spaces
• Reduce overhead air conditioning or heating vents directing dry air at the face

Other Evidence-Based Strategies

Flaxseed oil: Rich in ALA (alpha-linolenic acid), which the body can partially convert to EPA and DHA — though conversion is limited (typically <10%). Several small RCTs have shown flaxseed oil supplementation (1–2g/day) improves tear film osmolarity and reduces symptom scores, likely through both partial omega-3 conversion and direct anti-inflammatory effects of ALA.

Adequate hydration: Mild systemic dehydration reduces tear secretion and worsens aqueous-deficient dry eye. The lacrimal gland is a secretory organ that depends on adequate systemic hydration; 1.5–2.5 litres of water daily is a reasonable baseline.

Caffeine: An unexpected finding from several studies is that caffeine modestly increases aqueous tear production by stimulating the autonomic nervous system. Moderate coffee or tea consumption (1–3 cups/day) is unlikely to worsen and may marginally help aqueous-deficient dry eye in some individuals.

Omega-6 reduction: Excessive dietary linoleic acid (the dominant omega-6 in seed oils — soybean, corn, sunflower, safflower oil) competes with omega-3 metabolism and promotes a more pro-inflammatory prostaglandin profile in the tear film. Reducing ultra-processed foods and replacing seed oils with olive oil and avocado oil as primary cooking fats supports the omega-3:6 balance that benefits tear film composition. See our Seed Oils page for more.